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ABSTRACT 
The evaluation and interpretation of controls used in 
three commercially available quantification kits for 
forensic DNA analysis.  
 
Stephanie R. Schottke, B.S. 
 
 
This research presented an idea to aid crime laboratories in the selection of the best 
quantification method for use in DNA analysis in their laboratory. The goal of this research was 
to evaluate the suitability of using an external reference standard, the NIST SRM 2372 Human 
Quantitation Standard, to increase the quality of quantification results of human DNA analysis in 
commercially available kits. Additionally, the DNA standard included with the commercial kit, 
used for developing a standard curve, was evaluated for accuracy and stability beyond the 
recommended time frame. The commercial quantification kits tested were: Quantifiler® Trio 
DNA Quantification Kit (Applied Biosystems™, Life Technologies), Plexor® HY System 
(Promega Corporation), and Investigator® Quantiplex HYres (Qiagen). It was found that 
generally the concentration of the NIST SRM 2372 was not accurately quantifying in all three 
quantification kits. Furthermore, it was found that each standard curve dilution series varied in 
accuracy, as well as stability.  
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1. Introduction  
The quantification of human nuclear DNA is an important step in forensic DNA analysis.  
When suspected biological evidence is collected at a crime scene it is likely that the sample 
collected contains more than human DNA. DNA isolation techniques not only isolate human 
DNA from the sample, but they also can isolate non-human DNA such as, bacterial, fungal, 
plant, or animal [1]. Accurate determination of the quantity of human DNA present in a sample 
is required for further DNA analysis techniques. Successful completion of capillary 
electrophoresis and short tandem repeat (STR) analysis starts with the accurate DNA 
quantification and serves as quality assurance for the isolation and purification of the sample. 
Additionally, the Federal Bureau of Investigation’s (FBI) Quality Assurance Standards for 
Forensic DNA Testing Laboratories (Standard 9.3) states that a laboratory should have and 
follow a procedure for human DNA quantification [2]. 
The National Institute of Standards and Technology (NIST) created a Human 
Quantitation Standard (SRM 2372), which has been determined to be a stable, monitored 
standard that could reduce within- and among-laboratory variability [3]. The SRM 2372 can be 
utilized as standard DNA to determine a standard curve for quantification, and then be compared 
to unknown samples to determine the quantity of human DNA. In similar experiments with the 
Investigator® Quantiplex HYres kit, it was previously reported that the SRM 2372 was 
underestimated at lower dilutions of 5.24, 0.524, and 0.0524ng/uL [4]. 
Further, commercial quantification kits from various vendors have been developed to 
determine the amount of human DNA in a sample. These kits contain all the components to 
quantify DNA and they also include a standard DNA solution. This DNA standard is serially 
diluted to generate a standard curve to compare unknown quantities of DNA. The commercial 
kits provide a recommendation to prepare each standard DNA dilution series fresh, each time 
before analysis, and recommend a length of time for storage. This is due to DNA having the 
potential to form aggregates, and the tendency to bind to the plastic tubes it is being stored in [5] 
[6].  
The specific project goals of this research study was to evaluate the suitability of using 
the standard reference material (SRM) as an external standard of comparison to determine the 
quality of quantitative results of human DNA analysis in commercially available kits. 
Additionally, the DNA standard included with the commercial kit was evaluated for its quantity 
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and stability, beyond the recommended time frame. In the pursuit of these goals, the following 
objectives were tested:  
1. Evaluate the performance of the NIST SRM 2372- Human DNA Quantitation 
Standard and 
2. Evaluate the performance and stability of the DNA standard solution included in 
three commercially available kits. 
a. Quantifiler® Trio DNA Quantification Kit (Applied Biosystems™, Life 
Technologies) 
b. Plexor® HY System (Promega Corporation) 
c. Investigator® Quantiplex HYres (Qiagen)  
 
2. Background and History of Quantification Methods 
2.1 DNA  
 DNA, or deoxyribonucleic acid is a molecule that contains the hereditary information for 
the cells of an organism; this genetic “programming” codes for the essential proteins needed for 
function of life. DNA is mostly found in the nucleus of the cell; however, there is some DNA 
found in the mitochondria of a cell. DNA found in the nucleus is known as nuclear DNA 
(nDNA), and DNA in the mitochondria is mitochondrial DNA (mtDNA) [7]. Nuclear DNA is 
inherited from both the father and mother in separately reproducing organisms, while 
mitochondrial DNA is only inherited from the mother. In forensic DNA analysis, an individual’s 
genetic profile can be obtained from specific regions (loci) in the nuclear DNA.  
Human nuclear DNA consists of two long polynucleotide chains composed of four 
possible nucleotides wound together in a double helix structure. Nucleotides are composed of a 
five-carbon sugar (deoxyribose), a phosphate group, and a nitrogen-containing base. There are 
four possible bases; adenine (A), cytosine (C), guanine (G), or thymine (T). Adenine is paired 
with thymine, and guanine is paired with cytosine. The nucleotides are linked to each other 
through an alternating sugar-phosphate “backbone” and the bases of the two complementary 
strands are linked by hydrogen bonds. The “backbone” created has 5’phosphate at one end and a 
3’ hydroxyl group at the other end. The two polynucleotide chains (strands) are opposed to one 
another, connecting the 5’ end of one strand to the other strand 3’ end, which is called 
antiparallel. The strands bound together are considered complementary, as seen in Figure 1 [8]. 
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Figure 1. DNA and its building blocks. [8] 
 
 All of the DNA in a cell is known as the organism’s genome; the genome in humans 
separated into 22 autosomal homologous chromosome pairs. An additional pair of chromosomes 
are called the sex chromosomes and is made up of X and Y chromosomes. Males normally have 
one X and Y chromosome, while females have two X chromosomes. A chromosome consists of 
a DNA molecule wrapped around proteins, called histones, and are compacted into an “X” like 
structure, with an exception for the Y chromosome in males, which is compacted into a “Y” 
shape. Twenty-three chromosomes are inherited from the mother and 23 from the father; those 
23 chromosomes from each parent are similar to each other when they combine, but not identical 
in genetic material, making them homologous [8].  
 Chromosomes contain genes, which are the protein coding regions of the DNA. The 
genes are made up of introns and exons. Introns are regions of the gene that do not directly code 
for proteins, whereas exons do [9]. These genes are located in the same region on the 
chromosome called a locus in each individual. However, genes can be different in each person 
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and these variations in genes are called alleles. If alleles in the homologous chromosome pair are 
identical it is called homozygous, and if they are different it is called heterozygous [10].  
 The cells in the human body have a ploidy, or the number of sets of chromosomes 
contained in the cell, associated with them. The chromosomal genetic material or autosomal 
material is considered to be in a diploid state. This means that the autosomal material contains all 
46 chromosomes inside each nucleus. The gametes (sperm or egg) in the body are considered to 
be in a haploid state, which contain only half the chromosomes, 23, in each nucleus because of 
meiosis. The combination of chromosomes leads to genetic differences between individuals, with 
an exception for identical twins. Usually, chromosomes do not combine in the same manner 
every time due to the laws of segregation and independent assortment during meiosis. In 
conception when egg and sperm combine the zygote becomes diploid [8] [10].  
In the field of forensic DNA analysis, the characterization of alleles present a locus is 
called a genotype, and the combination of genotypes, at multiple loci is called a DNA profile. 
There are multiple processes to obtain a DNA profile. DNA has to be present and sufficient in 
integrity for processes, such as polymerase chain reaction (PCR) to work. The concentration of 
DNA present in a sample is measured in nanograms (ng) or nanograms per microliter (ng/uL). 
The target amount of DNA used for forensic DNA analysis is usually about 0.5 to 1 nanogram 
[1].  
 
2.2 DNA Isolation/ Purification 
 Cells are designed to protect the DNA from the environment within the nucleus. The 
process of isolating and purifying DNA from a biological sample is also known as DNA 
extraction in forensic DNA analysis. DNA contained in a sample should be separated from all 
other cellular material. If the cellular debris are not separated from the DNA it will interfere with 
the analysis results. Many different types of extraction methods have been developed because of 
the desire to study and use DNA from many cell types. Particular methods have been developed 
for extracting DNA from different types of cells, such as bone, hair, or blood [1]. 
There are many types of commercial kits containing a series of reagents, tubes, and 
substrates; however, they all follow similar principles. The first step involves lysing the cells to 
release the DNA, or rupturing open the cells and breaking down the cell membranes and other 
cellular material. A commonly used enzyme proteinase is added to break down proteins, and 
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sodium dodecyl sulfate (SDS), a detergent, is added to lyse the membranes. After lysing, 
extraction techniques use either affinity or non-affinity methods of removing DNA from the 
solution.  
In non-affinity methods, all other cellular material is removed leaving the DNA in 
solution; likewise, the affinity methods remove DNA from the solution. Examples of non-affinity 
methods are the organic extraction method or phenol- chloroform, salt precipitation, and chelex. 
Affinity methods can utilize glass-milk/silica gel, silica-coated magnetic beads, or antibody-
coated magnetic beads. Nonetheless, with either type of method the DNA is separated from the 
other biological material, suspended into solution, and then can be used for further DNA analysis 
[11] 
 
2.3 DNA Quantification  
DNA quantification is of great importance for successful DNA analysis. When DNA is 
extracted from a biological sample, it is possible that DNA from other sources such as bacteria, 
plants, or animals is also extracted because DNA “acts” the same in all organisms. For human 
identification, the other sources of DNA are irrelevant and therefore the quantity of human DNA 
in the sample needs to be assessed. Furthermore, the FBI’s quality assurance Standards for 
Forensic DNA Testing Laboratories states in Standard 9.3, “... laboratory shall have and follow a 
procedure for evaluating the quantity of the human DNA in the sample where possible” [2]. 
DNA amplification processes are reliant on the amount of DNA in a sample. Too much or too 
little DNA can affect later processes [1].  
 
2.3.1 History of Quantification 
There are commercial kits that contain the necessary reagents required to perform a DNA 
quantification today. However, prior methods of quantitation were not always species-specific, 
meaning that the technique could not differentiate between human DNA and other types of 
DNA. One method utilized is ultraviolet (UV) spectroscopy. This method reads the absorbance 
of the aromatic rings in the DNA strands [12]. Double stranded DNA (dsDNA) has an absorption 
of 260 nanometers (nm). However, when strands are denatured (become single stranded 
(ssDNA)), the UV absorption (280 nm) increases by 20-30%. Thus, samples are analyzed at 
260nm and 280nm and used an optical density ratio of 260/280 is used to assess the purity of the 
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sample and determine the amount of DNA present. If a sample has a ratio value of 1.8 to 2.0 the 
sample is considered pure; if lower than 1.8 there is a chance of a contaminating UV-absorbing 
substance, such as left over phenol-chloroform from an organic extraction [13]. 
Other methods used previously were yield gels and slot blots. Yield gels involved gel 
electrophoresis and staining with ethidium bromide. Ethidium bromide is an intercalating dye 
that binds between the DNA bases. A conformational change occurs when the ethidium bromide 
is incorporated and then it fluoresces when exposed to UV light [14]. The amount of 
fluorescence is proportional to the amount of DNA present in the sample. This process is not 
very sensitive, not specific, and consumes are large amount of the sample. Additionally, 
ethidium bromide is a carcinogenic material. 
 The slot blot method is a method that is specific for human and other primates. It uses a 
molecular probe that is 40 base pairs and can be found on chromosome 17. A chemiluminescent 
dye is attached to the probe and DNA is captured onto a nylon membrane. The DNA is washed 
with the probe/dye combination. The probe binds to the DNA and the amount of color a sample 
displayed from the dye was compared to a set of standards, or known quantities of DNA to 
estimate the amount of DNA present in a sample [15]. 
 
2.3.2 Polymerase Chain Reaction (PCR)  
As the field of forensic DNA analysis advanced, the process of polymerase chain reaction 
(PCR) was invented by Kary Mullins. The PCR process involves cycles of denaturing, annealing, 
and extending DNA strands in a mixture of primers, polymerase, and deoxyribose nucleoside 
triphosphates (dNTPs), or free DNA bases. The cycles are regulated by temperature, and the 
process is similar to making paper copies on a copy machine. Primers are small DNA pieces that 
“flank” regions of DNA that are to be replicated. Polymerase is an enzyme that builds up the new 
DNA strands after reading a complementary DNA strand, and dNTPs are the nucleotide bases 
that the polymerase can use to build the new strands [1]. 
 
2.3.3 PCR-based Quantification 
In Figure 2, each initial dsDNA strand is denatured into two ssDNA strands. Forward and 
reverse primers flank a human specific region of DNA and are annealed to the strands. The 
extension process allows the polymerase to move along the ssDNA strands and make them into 
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dsDNA strands incorporating the dNTPs. Then this cycle is repeated many times, usually 
between 25-30 cycles, creating an exponential amount of copies of the DNA. Although methods 
can vary slightly, usually the denaturation occurs around 94°C for about 30 seconds to 1 minute. 
Annealing occurs around 60°C for 30 seconds to 1 minute, and extension occurs around 72°C for 
about 1 minute. Methods can also include an initial incubation period to denature the DNA 
strands and prepare the polymerase enzyme, as well as a final extension period to make sure all 
new strands have been completed [1]. 
 
Figure 2. DNA amplification process with polymerase chain reaction. [1] 
 
 Using PCR technology the quantity of human DNA could be more accurately 
determined. One of the first methods to utilize a PCR system is the AluQuant quantitation 
system. This system uses an Alu sequence which is a highly repeated sequence found throughout 
the human genome, and an enzymatic reaction to produce light. The intensity of the light is 
measured and it is proportional to the amount of Alu regions amplified. The intensity of the light 
from the unknown samples are compared to a series of known DNA concentrations. Therefore, 
the quantity of DNA in the unknown samples could be determined [13]. 
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End-point PCR is similar to this process; however, it uses a fluorescent intercalating dye 
such as SYBR Green and measures the fluorescence of the sample with the dye.  More advanced, 
real-time quantitative PCR (qPCR) is the process of watching the amplification process in “real-
time.” Instruments that perform qPCR analyze the data collected after every amplification cycle. 
Quantitative PCR systems use human specific, and more recently, male specific primers and 
fluorescent reporter dyes to measure the quantity of DNA as it amplifies. Vendors that use qPCR 
have variations in the molecular process to enhance the results of the PCR [13]. 
 When analyzing real-time PCR data there are three phases in the process; exponential, 
linear, and plateau amplification regions (Figure 3). The exponential growth phase is when PCR 
efficiency is at 100%, and there is an abundance of all the reaction components. The linear phase 
is when the amplification efficiency begins to decrease because one or more of the components 
are decreasing, however copies of DNA are still being produced. The plateau phase is when the 
PCR reaction has stopped and one or more reaction components are gone. The threshold, a point 
at which a sample can be quantified, is determined by the instrument and is dependent on how 
much DNA template was present. The “Ct” value is the cycle at which the fluorescence of a 
sample crosses that threshold [16]. 
 
Figure 3. Real-time PCR phases of amplification. [1] 
 
2.4 Commercially Available Kits  
 Quantification kits are commercially made for laboratories and contain all of the 
reagents, buffers, primers, reaction mixes, etc., that are required to complete the process. 
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Additionally, they contain a DNA standard to create a standard curve, of which to evaluate the 
quantities of unknown samples. Each manufacturer has unique formulas and processes to 
quantify DNA. Likewise, the DNA standard used to determine the quantity of DNA in a sample 
are different for each kit. A laboratory must evaluate each kit for its sensitivity, specificity and 
accuracy to determine which would be suitable for their needs. 
 
2.4.1 Quantifiler® Trio DNA Quantification Kit (Applied Biosystems™, Life Technologies)  
 The quantification kit from Applied Biosystems™, Quantifiler® Trio allows laboratories 
to obtain the quantity of total human and total male DNA at the same time. According to Life 
Technologies, this kit is highly accurate, sensitive, and specific. The kit can determine the ratio 
of human male to female DNA (1:4000 or greater), has a less than 1 pg/uL limit of detection, and 
is able to quantify concentrations from 0.005ng/uL to greater than 50 ng/uL. Quantifiler® Trio 
can predict the quality of the DNA sample, by using two autosomal regions, and results are 
obtained in about an hour. Importantly, the kit uses TaqMan® real-time PCR technology.  
Quantifiler® Trio uses three human-specific target loci: a small autosomal (80 base pairs) 
multicopy diploid target, a large autosomal (214 base pairs) multicopy diploid target, and a small 
Y-chromosome haploid multicopy target (75 base pairs).  The small autosomal target is the 
primary quantification target and the large autosomal target is mainly used to evaluate DNA 
degradation. It also includes a synthetic internal positive control (IPC) (130 base pairs). The 
positive control is designed to not bind to the human DNA.  Each of these targets have a 
different dye/quencher combination to be read by the real-time PCR instrument. The DNA 
standard included in the kit is a pooled, human genomic, smaller molecular weight DNA. When 
using the Quantifiler® THP DNA Dilution Buffer the diluted standards can be stored in low-
binding microcentrifuge tubes for up to two weeks at 2-8°C. Additionally, the kit also contains 
reaction and primer mix. The components of these reagents can be seen in Table 1. The 
Quantifiler® Trio kit is designed for use with the Applied Biosystems® 7500 Real-Time PCR 
System [17]. 
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Table 1. The reagents, contents, quantity, and storage the reagents of the Quantifiler® Trio 
Kit. [17] 
 
2.4.1.1 5’ nuclease assay- TaqMan® 
 A 5’ nuclease assay using TaqMan® technology, is a process of DNA quantification by 
which a molecular probe bound with a fluorescent reporter dye and a non-fluorescent quencher 
dye are hybridized to a DNA strand. A fluorescent reporter dye is a dye that emits fluorescence 
that can be read by the real-time PCR instrument. The non-fluorescent quencher suppresses the 
fluorescence of the reporter dye by Förster-type energy transfer [18]. The probe is positioned on 
the DNA strand between the forward and reverse primers which flank the target region and direct 
DNA polymerase where to start and stop. As the polymerase moves down the DNA producing a 
new strand, the probe is cleaved from the DNA separating the fluorescent reporter dye from the 
non-fluorescent quencher. Thus, allowing the fluorescence of the reporter dye to be emitted. An 
increase in fluorescence signal is read as more cycles occur [1] [17]. 
A 5’ nuclease assay process occurs every cycle during the amplification of DNA. The 
first step seen in Figure 4.a) is the polymerization of the TaqMan® probe to a complementary 
DNA sequence between the forward and reverse primer sites. “P” is the Taq DNA Polymerase 
enzyme, “R” is the reporter dye, and “NFQ” is the nonfluorescent quencher. Figure 4.b) is the 
strand displacement and at this point the reporter dye is still suppressed by the non-fluorescent 
quencher. It is important to note that the Taq DNA polymerase enzyme will only cleave probes 
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that are hybridized to the target DNA and for that reason there is no nonspecific amplification to 
be detected [17]. 
 
Figure 4. a) (top) The polymerization of the probe to the strand of DNA. b) (bottom) The 
strand displacement and polymerization of the strand begins. [17] 
 
 In Figure 5.a) the polymerization of the strand continues and the probe is cleaved from 
the strand. Here, the reporter dye will fluoresce because of the separation from the non-
fluorescent quencher. In Figure 5.b) the 3’ end of the TaqMan® probe is blocked by the non-
fluorescent quencher so there is no extension of the probe into the new strand and the reporter 
dye is still emitting light. This process repeats on available DNA strands until one or more 
reaction components are used up. The fluorescence is read after each cycle by the Real-Time 
instrument [17]. 
 
 
Thesis-SS-MS-2016 
 12 
 
 
Figure 5. a) (top) The cleavage of the probe from the DNA strand. b) (bottom) The 
completion of polymerization of the DNA strand, however there is no extension of the probe 
because of non-fluorescent quencher blocking the 3’ end. [17] 
 
Table 2. contains the targets of the system, the length of the target, the ploidy, copy 
number, and the dye/quencher used for identification. The MGB probe either contains a FAM™ 
or VIC® reporter dye linked to the 5’ end, and there is a minor groove binder (MGB) and 
nonfluorescent quencher (NFQ) at the 3’ end. A minor groove binder increases the melting 
temperature without increasing the probe length [19]. The QSY probe either contains an ABY® 
or JUN® reporter dye linked to the 5’ end, and there is a NFQ QSY® at the 3’ end [17]. 
 
Table 2. Quantifiler® Trio Quantification Kit targets. [17] 
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2.4.1.2 Quantifiler® Trio Analysis Parameters 
 There are various analysis parameters that should be met when using the Quantifiler® 
Trio kit in order to achieve more accurate results. The standard curve is evaluated using the 
equation: CT = m[log(Qty)] +b. The equation is the threshold of the standard dilutions versus the 
quantity of the standards.  
The slope, or “m” has a different range of acceptable values for each target. The small 
autosomal target standard curve should have a slope in the range of -3.0 to -3.6 with an average 
of -3.3. The large autosomal target standard curve should have a slope in the range of -3.1 to -3.7 
with an average of -3.4. The male target should have a range of -3.0 to -3.6 with an average of -
3.3.  
Each target’s standard curve should have an R2 ≥ 0.99; the measure of the fit of the data 
points to the linear regression line. There will be variation in the “b” or y-intercept of the graph 
depending on the experiment and other various factors. The kit claims to have a linear regression 
from 100ng/uL to 5pg/uL, and a slope of -3.3 is equivalent to 100% efficiency of the PCR 
process [17]. 
 
2.4.2 Plexor® HY System (Promega Corporation)  
 The Plexor® HY System is a system that can quantify both total human and male DNA 
simultaneously. It can detect down to 6.4pg of DNA, contains an internal PCR control (IPC), and 
utilizes melt-curve analysis to control for potential false-negative or false-positive readings. The 
kit can be stored at room temperature because it involves hot-start chemistry. Plexor® HY 
System is optimized for the Applied Biosystems 7500 and 7500 FAST Real-Time PCR systems, 
as well as Stratagene Mx3005P® and Mx3000P® qPCR systems. Additionally, Plexor® 
Analysis Software is available for free download through Promega Corporation. The kit 
includes: Master Mix, Primer/IPC Mix, Genomic DNA standard (50 ng/uL), and amplification 
grade water. Importantly, the DNA standard once thawed at 2-10°C should not be refrozen, and 
the number of freeze-thaw cycles should be minimized. It is not recommended to store diluted 
standards [5]. 
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2.4.2.1 Plexor® HY PCR Process 
The Plexor® technology uses modified nucleotide and it involves the use of two primers. 
The human primers amplify a 99 base pair target on chromosome 17, and the male primers 
amplify a 133 base pair region on the Y chromosome. One primer contains a modified nucleotide 
(iso-dC) and a 5’ fluorescent reporter, while the other primer is unmodified. The reporter dye 
used on the human primers is fluorescein (FL), while the male primers use CAL Fluor® Orange 
560 dye, and the internal positive control uses CAL Fluor® Red 610 dye. In the reaction mix 
there is a fluorescent quencher known as Dabcyl-iso-dGTP that is linked to the modified iso-dC 
nucleotide during the amplification process. When the quencher is in position it stops the 
fluorescence of the reporter; thereby, a decrease in fluorescence is accompanied by an increase in 
product. Figure 6. is a diagram of the real-time PCR process for the Plexor® HY technology. 
During the primer annealing and extension, the modified nucleotide (iso-dC) and the fluorescent 
reporter are attached to the DNA strand. Then Taq polymerase moves along the template 
creating a new strand, thereby incorporating the Dabcyl-iso-dGTP quencher onto the strand, and 
the fluorescent reporter dye is quenched [5]. 
 
 
Figure 6. Diagram of Plexor® real-time PCR process. [5] 
 
 2.4.2.2 Plexor® HY Analysis Parameters  
There are analysis parameters that should be met in order to achieve more accurate results 
with the Plexor® HY system. The standard curve is evaluated by the equation: y=mx+b. The “x” 
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is the log concentration of the standards and “y” is the Cq, or threshold.  The human target 
standard curve should have a slope in the range of -3.2 to -4.0 with a R2 ≥ 0.990. The male target 
standard curve should have a slope in the range of -3.0 to -3.6 with a R2 ≥0.990.  A slope of -3.3 
indicates 100% efficiency of the PCR process [5]. 
 
2.4.3 Investigator® Quantiplex HYres (Qiagen)  
 The Investigator® Quantiplex HYres is a commercial kit that can also perform 
simultaneous total human and male DNA quantification. It can quantify 50 ng/uL to about 
0.5pg/uL, with a linear range between 20 ng/uL and 4.9pg/uL. For total human quantification, it 
amplifies a 146 base pair autosomal multi-copy target location utilizing the green FAM dye. 
Male DNA quantification is determined by a 129 base pair Y chromosome multi-copy region 
with a red Cy5 dye. Additionally, the kit contains a 200 base pair internal amplification control 
(IC) labeled with the yellow VIC dye. The kit contains: reaction mix, primer mix, nucleic acid 
dilution buffer, and control DNA (20 ng/uL). The reaction mix (Reaction Mix YQ) contains 
DNA polymerase and buffer formulated for high sensitivity and speed. The control DNA 
(Control DNA Z1) is a mixture of male and female DNA, where in 1uL it contains 20 ng of 
human DNA and 12.3ng of male DNA. When the DNA standard is diluted with the QuantiTect 
Nucleic Acid Dilution Buffer it is stable for at least one week at 2-8°C. It has also been 
streamlined for the Rotor-Gene Q, Applied Biosystems 7500 Real-Time PCR system for Human 
Identification, and Applied Biosystems 7500 and 7500 Fast Real-Time PCR systems [20]. 
 
2.4.3.1 Scorpions® Primers  
The Quantiplex HYres system employs Scorpions® primers and fast PCR chemistry. The 
Scorpions® primers are a combination of a PCR primer linked to a probe that contains a 
fluorophore and a quencher. The fluorophore reacts with the quencher, which reduces 
fluorescence. Then, during the amplification process the fluorophore and quencher are separated. 
Therefore an increase in fluorescence indicates more product. Figure 7. diagrams how the 
Scorpions® primers function. The primer/probe combination is attached to the DNA strand. The 
loop contains a complementary strand of DNA to the target. When the probe is heated through 
the PCR process the probe unfolds. When the PCR process cools the complementary strand in 
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the probe anneals to the DNA strand. The fluorophore and quencher are then separated and the 
fluorophore can emit light [20]. 
 
Figure 7. Diagram of the Scorpions® primers in the Investigator® Quantiplex 
HYres kit. [20] 
 
2.4.3.2 Investigator® Quantiplex HYres Analysis Parameters 
 There are parameters that should be met in order to achieve the best results using the 
Investigator® Quantiplex HYres kit. The standard curve is evaluated by the equation: y=mx+b. 
Where “x” is the log of the concentration of the standards and “y” is the CT, or threshold. For 
both the human and male target standard curves, the slope should be in the range of -3.0 to -3.6. 
It should also have a R2 ≥0.990. A slope of -3.3 is considered to be a 100% efficient PCR process 
and the internal control (IC) should have a threshold of around 31. The kit claims to have 
standard curve detection range from 75ng/uL to 0.5pg/uL, and is highly linear between 20ng/uL 
and 4.9pg/uL [20]. 
 
2.5 DNA Stability  
 The quality of a DNA sample can be decreased if the sample is not properly stored. Moist 
biological samples should be dried before packaging to prevent mold and bacteria growth that 
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are inevitably mixed in with the sample. Samples should be kept dry and cold, again to prevent 
mold and bacteria growth. Bacteria and mold can contain DNases which are DNA digesting 
enzymes that will slowly break down the DNA present in a biological sample. A quality sample 
can be lost if not stored properly. DNA that has been extracted should be stored in water or 
buffer solution at 4°C or -20°C, or for long-term storage at -70°C [21]. 
Extracted DNA is usually stored in some kind of polypropylene microcentrifuge tube. 
However, numerous studies have found that in long-term storage, DNA tends to bind to 
polypropylene microcentrifuge tubes. In one study, it was found polyallomer tubes, or specially 
designed low-binding polypropylene tubes had little DNA binding to the tube, but certain types 
of ordinary polypropylene tubes had almost a 75% adsorption rate [22]. A NIST study in 2005 
also found that in low quantities of DNA, a significant portion of the DNA binds to a 
polypropylene tube [23]. Additionally, another study found that certain chemicals in 
polypropylene/plastic additive tubes leach into the sample and have an absorbance between 220 
and 260 nm. This could interfere with quantitative UV absorbance results [24]. Many low-
binding tubes are polypropylene tubes that feature a special bonding of the polymer that reduces 
nucleic acid binding [25] [26] [27].  
 
3. Materials and Methods 
3.1 Serial Dilution Series using the NIST SRM 2372 Male DNA Component A 
 The NIST Standard Reference Material (SRM) 2372 Male DNA Component A (57ng/uL) 
was initially diluted 1:1 for the second standard, and then a 1:2 dilution series in low TE-4 buffer 
to the final concentration in regular microcentrifuge tubes (Corning® Costar® cat#3620). 
Concentrations were: 57, 28.5, 7.125, 1.78, 0.4453, 0.113, 0.0278, 0.0069, and 0.0017ng/uL. 
Each concentration was replicated in triplicate in the sample plates for the Quantifiler® Trio, 
Plexor® HY, and Investigator® Quantiplex HYres kits to assess the accuracy of the results 
obtained by these kits. A new serial dilution was prepared for each kit type to avoid prolonged 
storage.  
In RStudio® statistical analysis software, the log of the measured values obtained for 
each target were plotted against the log of the expected values at each dilution. This was done 
using the “xyplot” lattice function which produces bivariate scatterplots [28]. The summary 
outputs the residuals, coefficients, residual standard error, r-squared values, degrees of freedom, 
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F-statistics, and the p-value. The focus for this experiment was on the r-squared values, degrees 
of freedom, and the p-value, to determine whether or not the measured values are statistically 
significantly different from the expected values. A p-value of less than 0.05 was considered 
significantly different.  
 
3.2 Commercial Kit DNA Standards Evaluation of Performance and Stability 
 For the Quantifiler® Trio, Plexor® HY, and Investigator® Quantiplex HYres kits, the 
serial dilution series was followed as outlined in the protocol. The dilution concentrations are 
listed for each kit in Tables 3, 4, and 5. The serial dilution series for each kit was prepared once a 
week, for three weeks: week 1 being the oldest, week 3 being the newest. While a new series was 
being prepared, the old series was placed out at room temperature, to mimic usage of the series. 
In the kits where undiluted DNA is used as the first standard, enough volume was aliquoted. A 
series was created for both low-binding (Corning® Costar® cat#3207) and regular (Corning® 
Costar® cat#3620) microcentrifuge tubes for each week. Every sample was replicated in 
triplicate in the sample plates. This arrangement allows for the assessment of the stability of the 
standard DNA once diluted, as well as the evaluation of the usage of a low-binding or regular 
microcentrifuge tube to prevent DNA binding to the tube, increasing the stability of the dilution 
series.  
 For each dilution, the average for both the low binding and regular microcentrifuge tubes 
was calculated and plotted over three weeks’ time. Additionally, a paired t-test for sample means 
was calculated to compare the low binding and regular microcentrifuge tubes for the entire three 
weeks with Microsoft Excel® data analysis software add-in. The t-stat and P(T<=t) two tail 
values were recorded from the Excel® output. A p-value of less than 0.05 was considered 
significantly different. The difference of the means was also calculated and with the “Descriptive 
Statistics” the mean difference, standard deviation, and confidence level (95%) values were 
obtained.  
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Table 3. The standard dilution series for Quantifiler®Trio DNA Quantification Kit. [17] 
 
 
Table 4. The standard dilution series for Plexor® HY System. [5] 
 
 
Table 5. The standard dilution series for Investigator® Quantiplex HYres. [20] 
 
3.3 Quantifiler® Trio Quantification Kit 
 The Quantifiler® Trio Quantification Kit (lot# 1511018), reactions were prepared 
according to the protocol: 8uL of Quantifiler® Trio Primer Mix and 10uL of Quantifiler® THP 
PCR Reaction Mix for each sample was used to calculate the total volume of master mix. Then 
18uL of master mix was added to each appropriate well in a 96-well reaction plate and 2uL of 
either sample, standard, or control for a total of 20uL. The plate was sealed with an optical 
adhesive cover. The Applied Biosystems™ 7500 Real-Time PCR instrument was used with the 
following cycling parameters: hold at 95°C for 2 minutes, then 40 cycles of 95°C for 9 seconds 
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to 50°C for 30 seconds. Data was analyzed in the HID Real-Time PCR Analysis Software 
according to the protocol.  
 
3.4 Plexor® HY System 
 The Plexor® HY System (lot# 0000194319), reactions were prepared according to the 
protocol: 10uL of Plexor® HY 2X Master Mix, 7uL of amplification grade water, and 1uL of 
Plexor® HY 20X Primer/IPC Mix for each sample was used to calculate the total volume of 
master mix. Then 18uL of master mix was added to each appropriate well in a 96-well reaction 
plate and 2uL of either sample, standard, or control for a total of 20uL.  The plate was sealed 
with an optical adhesive cover. The Applied Biosystems ™ 7500 Real-Time PCR instrument 
was used with the following cycling parameters: hold at 95°C for 2 minutes, then 38 cycles of 
95°C for 5 seconds to 60°C for 35 seconds, followed by the “Dissociation Function” default 
setting. Data was analyzed in the Plexor® Analysis Software-Forensics according to the 
protocol.  
 
3.5 Investigator® Quantiplex HYres 
 The Investigator® Quantiplex HYres (lot# 154013504) reactions were prepared 
according to the protocol: 9uL of Reaction Mix YQ and 9uL of Primer Mix IC YQ for each 
sample was used to calculate the total volume of master mix. Then 18uL of master mix was 
added to each appropriate well in a 96-well reaction plate and 2uL of either sample, standard, or 
control for a total of 20uL. The plate was sealed with an optical adhesive cover. The Applied 
Biosystems™ 7500 Real-Time PCR instrument was used with following cycling parameters: 
hold at 95°C for 3 minutes, followed by 40 cycles of 95°C for 5 seconds to 60°C for 35 seconds. 
Data was analyzed in the HID Real-Time PCR Analysis Software according to the protocol.  
 
4. Results and Discussion  
4.1 Serial Dilution Series using the NIST SRM 2372 Male DNA Component A 
 The serial dilution series using the NIST SRM 2372 Male DNA Component A was 
performed to evaluate the accuracy of the various commercial quantification kits. The NIST 
serial dilution was defined by determining the concentration of each dilution using the standard 
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curve created using the DNA standard that comes with each kit. The standard curve slope, y-
intercept, R2, and efficiency for the sample plate with the NIST dilutions can be seen in Table 6.  
The slope and fit of the data to the linear regression line (R2) for each kit fell within the 
acceptable ranges provided by the manufacturers. This indicates that the standard curves were 
prepared properly and were reliable to compare unknown samples.  
The log of the expected value versus the log of the measured values for the quantification 
kits can be seen in Figures 8, 9, and 10, and the r-squared and p-values in Table 7.  
 
 
Table 6.  Standard Curve Results for sample plate containing NIST dilutions. 
 
  Slope Y-intercept R2 Efficiency (%) 
Quantifiler® Trio L-Auto -3.52 25.336 0.997 92.36 
 S-Auto -3.313 27.949 0.995 100.391 
 Male -3.213 26.92 0.997 104.756 
      
Plexor® HY Human -3.35 23.83 0.997 98.73 
 Male -3.31 24.72 0.993 100.41 
      
Quantiplex HYres Human -3.321 25.524 0.994 100.022 
 Male -3.299 24.841 0.998 100.97 
 
  
 
Figure 8. The log of the expected values versus the log of the measured values for the large 
autosomal, small autosomal, and male targets in the Quantifiler® Trio Quantification kit. 
N=80. 
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Figure 9. The log of the expected values versus the log of the measured values for the human 
and male targets in the Plexor® HY system. N=49. 
 
 
Figure 10. The log of the expected values versus the log of the measured values for the human 
and male targets in the Quantiplex HYres System. N=53. 
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Table 7. NIST r-squared and p-value results for Quantifiler Trio, Plexor HY, and Quantiplex HYres 
quantification kits. 
 Multiple R2 Adjusted R2 df p-value 
Quantifiler® Trio 0.9811 0.9808 79 2.20E-16 
Plexor® HY 0.9683 0.9676 48 2.20E-16 
Quantiplex HYres 0.9917 0.9916 52 2.20E-16 
p-value =0.05, Quantifiler® Trio (N=80), Plexor® HY (N=48), Quantiplex HYres (N=52) 
 
 When compared the expected values of the NIST serial dilution to the obtained measured 
values for this experiment it was found that they are statistically significantly different (Table 7). 
Therefore, each quantification kit did not quantify the NIST standard DNA to the expected 
values. Each quantification kit had a p-value of 2.20E-16 and highly linear regression lines (r-
squared values). The Plexor® HY system had the lowest r-squared values (multiple-0.9683, 
adjusted-0.9676), and the Quantiplex HYres system had the highest values (multiple-0.9917, 
adjusted 0.9916). This means that the Quantiplex HYres system data better fits the regression 
line and the expected values, as well as having less variation as a standard curve. However, the 
p-value still has to be considered and each kit was statistically significantly different. 
  The standard DNA solution used in the Quantiplex HYres kit is a mixture of male and 
female DNA, where in 1uL of sample there is 20ng of human DNA and 12.3ng of male DNA. 
Thus, during the analysis process the standard curves are evaluated using two different dilution 
series. The human target uses a four-fold dilution series with seven points starting at 20 to 
0.0049ng/uL. The male target starts at 12.3 to 0.012ng/uL with only 6 points. It is recommended 
not to use a seventh point in the male dilution series due to potential stochastic effects that could 
compromise the standard curve [20]. It is possible that because of the different standard curves 
utilized, that the specific male curve generated decreased the variability between the measured 
and expected values.  
 It is also possible that the standard curve at which we are determining these NIST SRM 
2372 values is not as accurate as believed. In the DNA analysis software, each standard in the 
dilution series is given a quantity, regardless if it is that quantity or not. This could have a major 
effect on the reported results for the NIST SRM 2372 dilution series. There is the potential that 
the standard curve has been skewed to a higher fluorescence and lower quantities of DNA could 
be overlooked because they are appearing to be minute.  
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If an external reference standard, such as the NIST SRM 2372, were to be used for the 
quantification kits for every time use, many serial dilutions and replicates should be performed to 
find where each concentration would lie in the standard curve for each particular kit and 
instrument. However, in this experiment the NIST SRM 2372 concentrations from the serial 
dilution did not quantify to the expected values.  
 
4.2 Commercial Kit DNA Standards Evaluation of Performance and Stability 
4.2.1 Quantifiler® Trio DNA Quantification Kit 
 The DNA standard that is supplied with the Quantifiler® Trio kit has a concentration of 
100ng/uL. The serial dilution has five concentrations: Standard 1 is 50ng/uL, standard 2 is 
5.0ng/uL, standard 3 is 0.50ng/uL, standard 4 is 0.05ng/uL, and standard 5 is 0.005ng/uL. The 
kit utilizes a large and small autosomal target as well as a male target. Therefore, a standard 
curve is constructed for each target. The average concentration for each standard over the three 
weeks for both low binding and regular microcentrifuge tubes were plotted for each target. The 
large autosomal, small autosomal, and male target plots can be seen in Figures 11, 12, and 13, 
respectively. Week one values were the oldest values, while week three values were the newest 
values.  
 The human target (Figure 11) values generally did not quantify at the expected values. 
The low binding tubes had higher concentrations in most cases than the regular tubes. 
Concentrations for both types of tubes, decreased over time. The regular microcentrifuge tubes in 
week one were actually closer to the expected values compared to the newest standard curve. 
The small target (Figure 12) concentrations for both tube types also decreased over time, with a 
spike in week two. Again, the values obtained were not close to the expected values. The small 
target is the primary quantification target and therefore should be the more accurate value. The 
male target (Figure 13) generally decreased over time except for the 50ng/uL concentration 
where it increased. The values obtained were also higher than the expected values.  
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Figure 11.  The average measured values for each standard at the large autosomal target over 
three weeks for both low binding and regular microcentrifuge tubes. Week one -oldest and 
week three-newest values. 
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Figure 12.  The average measured values of each standard at the small autosomal target over 
three weeks for both the low binding and microcentrifuge tubes. Week one -oldest values, 
week three -newest. 
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Figure 13.  The average measured values of each standard at the male target over three weeks 
for both the low binding and microcentrifuge tubes. The week one values -oldest and week 
three -newest.  
 
Additionally, the t-statistic, p-value and confidence interval for the comparison between 
low binding and regular microcentrifuge tubes at each standard dilution are tabulated in Table 8.  
Assuming a p-value of 0.05, a paired t-test was performed to see if the low binding tubes were 
effective at preventing DNA loss. The mean DNA lost (M= 2.2223, SD, 4.2023, N=9) was not 
significantly greater than zero (t (8) =1.5865, two-tail p=0.1513) providing no evidence that the 
low binding tubes are effective at 50ng/uL for preventing DNA loss. However, the 5, 0.5, 0.05, 
and 0.005ng/uL had a mean difference significantly greater than zero (see Table 8), providing 
evidence that the low binding tubes are effective at these standards for preventing DNA loss.  
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Table 8. The summary statistics for the Quantifiler® Trio kit. The mean difference between the low binding and 
regular microcentrifuge tubes for the total of three weeks. 
 
Sample  (ng/uL) 
Measured Mean 
Difference 
SD of the 
Difference t-value  p-value 
CI of the 
Difference 
50 2.2223 4.2023 1.5865 0.1513 3.2302 
5 0.359 0.3888 2.7704 0.0243 0.2989 
0.5 0.1103 0.0958 3.4549 0.0086 0.0737 
0.05 0.0123 0.0106 3.6599 0.0064 0.0082 
0.005 0.0014 0.0013 3.2412 0.01186 0.001 
Two- tail p-value= 0.05, N=9 for each standard 
 
  Largely, it appears in this experiment that the DNA standard solution is not quantifying at 
the expected values for the standard curve. Thus, it is difficult to tell exactly how much of a 
change is occurring because the stock DNA solution is not quantifying at the expected starting 
concentration. Over time, the DNA concentrations are decreasing. However, at low 
concentrations of DNA, low binding tubes are significantly better at preventing DNA loss. In 
order to more accurately determine the concentration of an unknown sample, it would be 
recommended to determine the concentration of the standard DNA solution to be used with an 
external reference standard. It would also be recommended, when storing minute amount of 
DNA for long periods of time, a low binding microcentrifuge tube should be used to prevent 
DNA loss. 
 
4.2.2 Plexor® HY System 
 The Plexor® HY Male Genomic DNA Standard has a concentration of 50ng/uL. The 
standard is serially diluted into seven concentrations: 50, 10, 2, 0.4, 0.08, 0.016, and 
0.0032ng/uL. It is recommended by Promega not to store the diluted DNA solutions [5]. The low 
binding and regular tube concentrations are plotted over the three-week time period for both the 
human and male targets in Figures 14 and 15, respectively.  
 In the human target (Figure 14), from expected concentrations 2ng/uL and lower, the low 
binding tubes had greater concentrations than the regular tubes, and both types of tubes 
decreased in concentration over time. The expected concentrations of 50 and 10ng/uL, there was 
more variation between higher concentrations for either low binding or regular tubes. Generally, 
the low binding tubes were closer to the expected value, and the regular tubes were below the 
expected value. In the male target (Figure 15) at the expected 0.4ng/uL standard and lower had 
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greater concentrations in low binding tubes compared to the regular tubes. Additionally, the 
week two values appeared to be closer to the expected value than week three. The week three 
values should have been the closest to the expected value because it was the newest standard 
curve.  
 
   
   
 
 
Figure 14.  The average measured values of each standard at the human target over three weeks for 
both the low binding and microcentrifuge tubes. The week one values are the oldest and week three 
is the newest. 
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Figure 15.  The average measured values of each standard at the male target over three weeks for 
both the low binding and microcentrifuge tubes. The week one values are the oldest and week three 
is the newest. 
 
Additionally, the t-statistic, p-value and confidence interval for the comparison between 
low binding and regular microcentrifuge tubes at each standard dilution are tabulated in Table 9.  
Assuming a p-value of 0.05, a paired t-test was performed to see if the low binding tubes were 
effective at preventing DNA loss.  
The mean DNA lost (M= -2.0506, SD, 5.311, N=6) was not significantly greater than 
zero (t (5) =-0.9458, two-tail p=0.3877) providing no evidence that the low binding tubes are 
effective at 50ng/uL for preventing DNA loss. Additionally, the 10 and 2ng/uL also provide no 
evidence that the low binding tubes are effective at preventing DNA loss. However, the 0.4, 
0.08, 0.016, and 0.0032ng/uL had a mean difference significantly greater than zero (see Table 9), 
providing evidence that the low binding tubes are effective at these standards for preventing 
DNA loss. 
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Table 9. The summary statistics for the Plexor® HY kit. The mean difference between the low binding 
and regular microcentrifuge tubes for the total of three weeks. 
 
Sample  (ng/uL) 
Measured Mean 
Difference 
SD of the 
Difference t-value  p-value 
CI of the 
Difference 
50 -2.0506 5.311 -0.9458 0.3877 5.5735 
10 -0.8293 3.7917 -0.5357 0.6151 3.9791 
2 0.4175 0.4263 2.3989 0.0617 0.4473 
0.4 0.1129 0.0355 7.7915 0.0006 0.0373 
0.08 0.0318 0.0103 7.5445 0.0006 0.0108 
0.016 0.0086 0.0029 7.3555 0.0007 0.003 
0.0032 0.0017 0.0006 7.008 0.0009 0.0006 
Two- tail p-value= 0.05, N=6 for each standard 
 
It appears in this experiment that the DNA standard solution is not quantifying at the 
expected values for the standard curve. Like the Quantifiler® Trio kit, it is difficult to tell exactly 
how much of a change is occurring because the stock DNA solution is not quantifying at the 
expected starting concentration. Most of the time the DNA concentrations are decreasing at each 
standard. However, at low concentrations of DNA, low binding tubes are significantly better at 
preventing DNA loss.  
In order to more accurately determine the concentration of an unknown sample using this 
kit, it would be recommended to determine the concentration of the standard DNA solution to be 
used with an external reference standard. Further experimentation with multiple lots of the DNA 
standard would also be recommended to see if this pattern continued.  
 
4.2.3 Investigator® Quantiplex HYres 
 The DNA standard utilized in the Investigator® Quantiplex HYres kit is a mixture of 
male and female DNA to mimic a mixed sample. In 1uL there are 20ng of human DNA and 
12.3ng of male DNA. The human and male targets use different standard curves. It is 
recommended that a seventh standard not be used in male determination because it is such a low 
quantity and it may have stochastic effects [20].  
 There was a great amount of variation over the time period between the low binding and 
regular tubes for each target. There is no general pattern for tube types over time for the human 
target (Figure 16). In some standards the concentration increased the following week, and in 
others it decreased. This indicates that this standard is not very stable for this portion of time. For 
Thesis-SS-MS-2016 
 32 
the male target (Figure 17), there was a dramatic decline in quantity of DNA by week one. This 
also indicates that the DNA standard is not stable once it has been diluted to be used as a 
standard curve, regardless of tube type. However, in most cases the low binding tube sample had 
a slightly higher concentration than the regular tube samples, but nothing substantial.   
   
   
 
Figure 16.  The average measured values of each standard at the human target over three 
weeks for both the low binding and microcentrifuge tubes. The week one values are the oldest 
and week three is the newest. 
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Figure 17.  The average measured values of each standard at the male target over three weeks 
for both the low binding and microcentrifuge tubes. The week one values are the oldest and 
week three is the newest. 
 
Like the Quantifiler® Trio and Plexor® HY kits, the t-statistic, p-value and confidence 
interval for the comparison between low binding and regular microcentrifuge tubes at each 
standard dilution are tabulated (Tables 10, 11).  Assuming a p-value of 0.05, a paired t-test was 
performed to see if the low binding tubes were effective at preventing DNA loss. Two t-tests 
were performed separately on the human and male targets due to the different standard curves 
used to determine the concentration in the analysis software. 
For the human target (Table 10), the mean DNA lost (M= -0.9979, SD, 0.4158, N=3) was 
not significantly greater than zero (t (2) =-4.156, two-tail p=0.0533) providing no evidence that 
the low binding tubes are effective at 20ng/uL for preventing DNA loss. Additionally, the 5, 
1.25, 0.313, 0.078, 0.0195, and 0.0049ng/uL standards also provided no evidence that the low 
binding tubes are effective at preventing DNA loss (see Table 10).  
 This concludes that there is no significant difference between using the low binding over 
regular microcentrifuge tubes for preventing DNA loss when using the Quantiplex HYres DNA 
standard. The statistics obtained do reflect that variance and no overall general pattern was seen 
in Figures 16 and 17.  
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Table 10. The summary statistics for the Quantiplex HYres human target. The mean difference between the low 
binding and regular microcentrifuge tubes for the total of three weeks. 
 
Sample  (ng/uL) Measured Mean Difference 
SD of the 
Difference t-value  p-value 
CI of the 
Difference 
20 -0.9979 0.4158 -4.156 0.0533 1.033 
5 0.0013 0.9527 0.0023 0.9983 2.3667 
1.25 0.0995 0.2947 0.5847 0.6179 0.732 
0.313 0.0142 0.0372 0.6614 0.5764 0.0923 
0.078 0.0032 0.0118 0.4789 0.6792 0.0293 
0.0195 0.0053 0.0046 1.973 0.1872 0.0115 
0.0049 0.0009 0.0014 1.0904 0.3894 0.0035 
Two- tail p-value= 0.05, N=3 for each standard 
 
For the male target (Table 11), the mean DNA lost (M= 0.8341, SD, 2.292, N=3) was not 
significantly greater than zero (t (2) =0.6303, two-tail p=0.5929) providing no evidence that the 
low binding tubes are effective at 12.3ng/uL for preventing DNA loss. Additionally, the 3.07, 
0.769, 0.192, and 0.012ng/uL standards also provided no evidence that the low binding tubes are 
effective at preventing DNA loss (see Table 11).  However, the 0.048ng/uL had a mean 
difference significantly greater than zero (M= 0.0036, SD, 0.0010, N=3) was not significantly 
greater than zero (t (2) =6.0625, two-tail p=0.0025) providing evidence that the low binding 
tubes was effective at this standard for preventing DNA loss. 
 
Table 11. The summary statistics for the Quantiplex HYres male target. The mean difference between the low 
binding and regular microcentrifuge tubes for the total of three weeks. 
 
Sample  (ng/uL) Measured Mean Difference 
SD of the 
Difference t-value  p-value 
CI of the 
Difference 
12.3 0.8341 2.292 0.6303 0.5929 5.6937 
3.07 0.1329 0.2333 0.9864 0.4279 0.5797 
0.769 -0.0207 0.1172 -0.3062 0.7884 0.291 
0.192 0.0511 0.0441 2.005 0.1827 0.1097 
0.048 0.0036 0.001 6.0625 0.0261 0.0025 
0.012 0.0028 0.0019 2.4935 0.1302 0.0048 
Two- tail p-value= 0.05, N=3 for each standard 
 
With the exception of the 0.048ng/uL standard, there was no evidence that the low 
binding tubes were effective at preventing DNA loss for this DNA standard solution. There is no 
significant difference between the low binding or regular microcentrifuge tubes. It would be 
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recommended that additional studies be performed on this DNA standard to evaluate the 
variance seen between each standard dilution. Like the other quantification kits, an assessment of 
the DNA standard that is provided should be tested with an external reference standard to 
determine the actual concentration of the DNA standard for that specific lot and instrument.  
 
5. Conclusions  
 In this experiment the Quantifiler® Trio Quantification Kit, the Plexor® HY system, and 
the Investigator® Quantiplex HYres kits, were evaluated to determine if an external reference 
standard would be suitable, as well as the performance and stability of their DNA standard 
control. A serial dilution created from the NIST SRM 2372 did not quantify at the expected 
values for any of the commercial kits. The obtained values were statistically significantly 
different from the expected values for each quantification kit. The Plexor® HY system had the 
lowest r-squared value, while the Quantiplex HYres had the highest r-squared value, indicating 
there was less variance in the values obtained when compared to the linear regression line.  
If an external reference standard, such as the NIST SRM 2372, is to be used in any of 
these commercial kits, it is recommended that the standard be serially diluted and replicated 
many times to determine the range of values expected for a specific instrument and lot number. It 
is possible that the standard curve generated in each kit could be affecting the results of the NIST 
concentrations. Generally, the value reported by NIST for the SRM 2372, did not quantify to the 
expected values in any kit.  
 Additionally, the DNA standard solutions that are utilized in each system did not quantify 
at the expected values for the standard curve. In all three kits, the reported standard DNA 
solution concentrations were usually higher than the expected value and there was a large 
amount of variation. In lower concentrations of DNA, it was found that using a low binding 
microcentrifuge tube statistically prevented DNA loss for the Quantifiler® Trio and Plexor® HY 
kits. There were no significant evidence toward low binding tubes preventing DNA loss for the 
Quantiplex HYres DNA standard.  
 Generally, it would be recommended that when storing a DNA standard, it should be 
stored in a low binding microcentrifuge tube to prevent DNA loss, as they prevented DNA loss 
in two of the three DNA standard dilution series. A low binding tube would be highly 
recommended for lower concentrations of DNA because binding may occur in regular tubes.   
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Overall, the DNA standards that are being utilized in each kit should be evaluated further 
before using them to create a standard curve. Theoretically, if a value is expected to be 50ng/uL 
and it is actually quantifying at 60ng/uL, the fluorescence being emitted is for a 60ng/uL sample 
and is being equated to 50ng/uL. This could be under or overestimating the unknown sample 
concentrations being determined from that standard curve. This could have impacted the values 
obtained for the time-trial of the serial dilutions for each kit, as well as, the NIST concentrations 
obtained. 
In order for an external reference standard to be used in a crime laboratory it would have 
to be extensively tested on each instrument and over many lot numbers to develop a range of 
expected values for the standard. Moreover, the DNA standards being used in each kit should 
also be tested on each instrument and over different lot numbers, as the standards in this 
experiment did not quantify to the expected values.  
Based on the observations in this experiment, no quantification kit out-performed the 
others in using an external reference standard to decrease inter- and intra- laboratory variability. 
The measured values for each kit were significantly different from the expected values. The 
Quantiplex HYres kit fit the linear regression line better than the other kits, but all the r-squared 
values were very high.  
Additional testing should be conducted using the NIST SRM 2372; further studies 
include, analyzing additional lots of the standard, analyzing the standard via gel electrophoresis, 
or examining the 260/280 ratio on a spectrophotometer. These further studies could also be 
applied to the DNA standard that is included in each quantification kit to evaluate it before use.  
Until both the DNA standard and the NIST SRM 2372 have been sufficiently evaluated 
for a particular lot number and particular instrument, the values should be taken as an estimate. 
The amplification process and further analyses should be conducted on unknown samples that 
have a very low quantification value, or no value at all. With the variance seen in this experiment 
between the expected value and the measured values, samples that are reporting no DNA present, 
may actually have DNA present and a DNA profile may be obtained.  
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